CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cryosite Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cryosite Ltd
13a Ferndell St, South granville
Phone: +61 288652000p:+61 288652000 SYDNEY, NSW  2142  Australia Ticker: CTECTE
Business Summary
Cryosite Limited is engaged in providing outsourced clinical trials depot services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Clinical trials and biological services logistics and Cord Blood and tissue storage. The Clinical trials and biological services logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological services and cell gene therapies depot services. Cord Blood and tissue storage segment provides storage of cord blood and tissue samples. Its facilities are purpose-built to store a range of biological materials, including Cell Banks (MCB, WCB), Mesenchymal Stromal Cell (MSC) Therapies, Tumour-Infiltrating Lymphocyte Therapies and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20246/30/2024Yes----

Industries
SIC Code Description
8099 Health and allied services, not elsewhere classified
8071 Medical laboratories
4222 Refrigerated warehousing and storage
8742 Management consulting services
4226 Special warehousing and storage, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board MarkKerr 12/8/2023 12/8/2023
Chief Executive Officer JohnHogg 2/22/2024 10/15/2020
Executive Director AndrewKerr 8/20/2024 2/22/2024
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 25 (As of 6/30/2024)
Outstanding Shares: 48,809,563 (As of 6/30/2024)
Shareholders: 557
Stock Exchange: ASX
Fax Number: +61 288652090


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024